Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial

被引：19

作者：

Shamji, Mohamed H. ^{[1
]}

Ceuppens, Jan ^{[3
]}

Bachert, Claus ^{[2
]}

Hellings, Peter ^{[4
]}

Placier, Gael ^{[5
]}

Thirion, Gaetan ^{[5
]}

Bovy, Nicolas ^{[5
]}

Durham, Stephen R. ^{[1
]}

Duchateau, Jean ^{[5
]}

Legon, Thierry ^{[5
]}

Pirotton, Sabine ^{[5
]}

机构：

[1] Imperial Coll London, MRC Asthma UK Ctr, Immunomodulat & Tolerance Grp, Allergy & Clin Immunol Inflammat Repair & Dev, London, England

[2] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium

[3] UZ Leuven, Dept Allergy & Clin Immunol, Leuven, Belgium

[4] UZ Leuven, Ear Nose & Throat Dept, Leuven, Belgium

[5] ASIT Biotech, Brussels, Belgium

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 141卷 / 01期

关键词：

IMMUNOTHERAPY; SET;

D O I：

10.1016/j.jaci.2017.09.013

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：448 / +

页数：8

共 11 条

[1] A set of pBR322-compatible plasmids allowing the testing of chaperone-assisted folding of proteins overexpressed in Escherichia coli [J].

Castanie, HP ;

Berges, H ;

Oreglia, J ;

Prere, MF ;

Fayet, O .

ANALYTICAL BIOCHEMISTRY, 1997, 254 (01) :150-152

[2] Type I interferonopathies: a novel set of inborn errors of immunity [J].

Crow, Yanick J. .

YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY I, 2011, 1238 :91-98

[3]

Fujimura Takashi, 2010, Allergology International, V59, P21, DOI 10.2332/allergolint.09-RAI-0151

[4] COMPLEMENTARY-DNA CLONING OF THE MAJOR ALLERGEN PHL-P-I FROM TIMOTHY GRASS (PHLEUM-PRATENSE) - RECOMBINANT PHL-P-I INHIBITS IGE BINDING TO GROUP-I ALLERGENS FROM 8 DIFFERENT GRASS SPECIES [J].

LAFFER, S ;

VALENTA, R ;

VRTALA, S ;

SUSANI, M ;

VANREE, R ;

KRAFT, D ;

SCHEINER, O ;

DUCHENE, M .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (04) :689-698

[5]

Noon L, 1911, LANCET, V1, P1572

[6] Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study [J].

Patel, Deepen ;

Couroux, Peter ;

Hickey, Pascal ;

Salapatek, Anne Marie ;

Laidler, Paul ;

Larche, Mark ;

Hafner, Roderick P. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) :103-U158

[7] Ara h 1 CD4+T cell epitope-based peptides: candidates for a peanut allergy therapeutic [J].

Prickett, S. R. ;

Voskamp, A. L. ;

Phan, T. ;

Dacumos-Hill, A. ;

Mannering, S. I. ;

Rolland, J. M. ;

O'Hehir, R. E. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (06) :684-697

[8] Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides [J].

Spertini, Francois ;

Perrin, Yannick ;

Audran, Regine ;

Pellaton, Celine ;

Boudousquie, Caroline ;

Barbier, Nathalie ;

Thierry, Anne-Christine ;

Charlon, Vincent ;

Reymond, Christophe .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (01) :239-U801

[9] Relationship Between the Type I Interferon Signature and the Response to Rituximab in Rheumatoid Arthritis Patients [J].

Thurlings, Rogier M. ;

Boumans, Marie ;

Tekstra, Janneke ;

van Roon, Joel A. ;

Vos, Koen ;

van Westing, Daisy Marie ;

van Baarsen, Lisa G. ;

Bos, Carina ;

Kirou, Kyriakos A. ;

Gerlag, Danielle M. ;

Crow, Mary K. ;

Bijlsma, Johannes W. ;

Verweij, Cornelis L. ;

Tak, Paul P. .

ARTHRITIS AND RHEUMATISM, 2010, 62 (12) :3607-3614

[10] The role of protein digestibility and antacids on food allergy outcomes [J].

Untersmayr, Eva ;

Jensen-Jarolim, Erika .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) :1301-1308

← 1 2 →